SG10201506767QA - Identification and enrichment of cell subpopulations - Google Patents
Identification and enrichment of cell subpopulationsInfo
- Publication number
- SG10201506767QA SG10201506767QA SG10201506767QA SG10201506767QA SG10201506767QA SG 10201506767Q A SG10201506767Q A SG 10201506767QA SG 10201506767Q A SG10201506767Q A SG 10201506767QA SG 10201506767Q A SG10201506767Q A SG 10201506767QA SG 10201506767Q A SG10201506767Q A SG 10201506767QA
- Authority
- SG
- Singapore
- Prior art keywords
- enrichment
- identification
- cell subpopulations
- subpopulations
- cell
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5011—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing antineoplastic activity
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0693—Tumour cells; Cancer cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- Oncology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Physics & Mathematics (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Food Science & Technology (AREA)
- Hospice & Palliative Care (AREA)
- General Engineering & Computer Science (AREA)
- Tropical Medicine & Parasitology (AREA)
- Toxicology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US38018110P | 2010-09-03 | 2010-09-03 | |
| US201161510413P | 2011-07-21 | 2011-07-21 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG10201506767QA true SG10201506767QA (en) | 2015-10-29 |
Family
ID=45048186
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG10201506767QA SG10201506767QA (en) | 2010-09-03 | 2011-09-02 | Identification and enrichment of cell subpopulations |
| SG2013024310A SG189212A1 (en) | 2010-09-03 | 2011-09-02 | Identification and enrichment of cell subpopulations |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG2013024310A SG189212A1 (en) | 2010-09-03 | 2011-09-02 | Identification and enrichment of cell subpopulations |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US9945842B2 (ja) |
| EP (2) | EP2611463A2 (ja) |
| JP (3) | JP6240504B2 (ja) |
| CN (2) | CN103313726B (ja) |
| AU (3) | AU2011295722B2 (ja) |
| CA (1) | CA2809864A1 (ja) |
| SG (2) | SG10201506767QA (ja) |
| WO (1) | WO2012031280A2 (ja) |
Families Citing this family (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2011295722B2 (en) | 2010-09-03 | 2016-04-21 | Abbvie Stemcentrx Llc | Identification and enrichment of cell subpopulations |
| US9778264B2 (en) | 2010-09-03 | 2017-10-03 | Abbvie Stemcentrx Llc | Identification and enrichment of cell subpopulations |
| NZ608814A (en) * | 2010-09-03 | 2015-06-26 | Stem Centrx Inc | Novel modulators and methods of use |
| SG10201601792UA (en) | 2010-12-08 | 2016-04-28 | Stemcentrx Inc | Novel modulators and methods of use |
| SA112330278B1 (ar) | 2011-02-18 | 2015-10-09 | ستيم سينتركس، انك. | مواد ضابطة جديدة وطرق للاستخدام |
| US9534058B2 (en) | 2012-02-08 | 2017-01-03 | Abbvie Stemcentrx Llc | Anti-CD324 monoclonal antibodies and uses thereof |
| DK2817620T3 (en) * | 2012-02-22 | 2016-09-05 | Verik Bio Inc | IMMUNTERY TREATMENT SYSTEM FOR TUMOR FORMATION AND PROGRESSION |
| AU2013203506B2 (en) | 2012-02-24 | 2016-06-09 | Abbvie Stemcentrx Llc | Novel modulators and methods of use |
| EP2817338B1 (en) | 2012-02-24 | 2017-07-26 | AbbVie Stemcentrx LLC | Dll3 modulators and methods of use |
| MX2014015656A (es) * | 2012-06-20 | 2015-06-23 | Merrimack Pharmaceuticals Inc | Cuantificacion de marcador en celulas individuales en secciones de tejido. |
| WO2014124326A1 (en) | 2013-02-08 | 2014-08-14 | Stem Centrx, Inc. | Novel multispecific constructs |
| WO2014130879A2 (en) | 2013-02-22 | 2014-08-28 | Stem Centrx, Inc. | Novel antibody conjugates and uses thereof |
| CA2909969A1 (en) * | 2013-05-13 | 2014-12-31 | Medimmune, Llc | Separation of recombinant polyclonal antibody multimers with minimal separation of monomers |
| ES2871418T3 (es) | 2013-08-28 | 2021-10-28 | Abbvie Stemcentrx Llc | Composiciones y métodos de conjugación de anticuerpos específicos de sitio |
| WO2015031541A1 (en) | 2013-08-28 | 2015-03-05 | Stem Centrx, Inc. | Novel sez6 modulators and methods of use |
| EP3065780A1 (en) | 2013-11-04 | 2016-09-14 | Pfizer Inc. | Anti-efna4 antibody-drug conjugates |
| AU2014346792A1 (en) | 2013-11-06 | 2016-06-02 | Abbvie Stemcentrx Llc | Novel anti-claudin antibodies and methods of use |
| SG11201604664PA (en) | 2013-12-12 | 2016-07-28 | Stemcentrx Inc | Novel anti-dpep3 antibodies and methods of use |
| US20150216908A1 (en) * | 2014-02-06 | 2015-08-06 | Steminent Biotherapeutics Inc. | Quadri-positive stromal cell (qpsc) population for superior cell protection and immunomodulation |
| US10308721B2 (en) | 2014-02-21 | 2019-06-04 | Abbvie Stemcentrx Llc | Anti-DLL3 antibodies and drug conjugates for use in melanoma |
| DK3137114T3 (da) | 2014-04-30 | 2021-01-25 | Pfizer | Anti-PTK7-antistof-lægemiddelkonjugater |
| EP3161480B1 (en) | 2014-06-25 | 2020-02-12 | Tel HaShomer Medical Research Infrastructure and Services Ltd. | Identification of cancer stem cell markers and use of same for diagnosis and treatment |
| TW201617368A (zh) | 2014-09-05 | 2016-05-16 | 史坦森特瑞斯公司 | 新穎抗ｍｆｉ２抗體及使用方法 |
| AU2016349644B2 (en) * | 2015-11-06 | 2022-11-24 | Ventana Medical Systems, Inc. | Representative diagnostics |
| CN107102141A (zh) * | 2016-02-23 | 2017-08-29 | 中国科学院生物物理研究所 | 分子标记物cd71及在子宫内膜癌诊断、分期及预后中的应用 |
| TW201805309A (zh) | 2016-04-21 | 2018-02-16 | 艾伯維史坦森特瑞斯有限責任公司 | 新穎抗－bmpr1b抗體及使用方法 |
| US10767164B2 (en) | 2017-03-30 | 2020-09-08 | The Research Foundation For The State University Of New York | Microenvironments for self-assembly of islet organoids from stem cells differentiation |
| CN110093311A (zh) * | 2018-01-29 | 2019-08-06 | 中国科学院上海生命科学研究院 | Icam-1标记及其应用 |
| CN109270262B (zh) * | 2018-10-08 | 2022-05-20 | 宁波美晶医疗技术有限公司 | 一种基于微流体技术的激光单细胞提取方法 |
| CN110567788B (zh) * | 2019-09-20 | 2022-02-11 | 北京蛋白质组研究中心 | 一种rna-蛋白质复合物的富集和鉴定方法 |
Family Cites Families (78)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4444487A (en) | 1979-07-02 | 1984-04-24 | Xerox Corporation | Multiple-flash fuser |
| GB8308235D0 (en) | 1983-03-25 | 1983-05-05 | Celltech Ltd | Polypeptides |
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| US4703004A (en) | 1984-01-24 | 1987-10-27 | Immunex Corporation | Synthesis of protein with an identification peptide |
| US4745055A (en) | 1985-05-07 | 1988-05-17 | California Biotechnology Inc. | Fused protein for enzyme immunoassay system |
| EP0256654B1 (en) | 1986-07-07 | 1996-09-18 | Centocor, Inc. | Chimeric murine/human immunoglobulin specific for tumour-associated 17-1A Antigen |
| GB8626412D0 (en) | 1986-11-05 | 1986-12-03 | Clark M R | Antibodies |
| US5202238A (en) | 1987-10-27 | 1993-04-13 | Oncogen | Production of chimeric antibodies by homologous recombination |
| EP0483247A4 (en) | 1989-07-21 | 1992-12-09 | Washington University | Recombinantly produced human membrane cofactor protein (mcp) |
| US6117985A (en) | 1995-06-16 | 2000-09-12 | Stemcell Technologies Inc. | Antibody compositions for preparing enriched cell preparations |
| JP2001502537A (ja) | 1996-10-15 | 2001-02-27 | ザ・リージェンツ・オブ・ザ・ユニバーシティ・オブ・カリフォルニア | ヒト前立腺ガンの進行の動物モデル |
| US7361336B1 (en) | 1997-09-18 | 2008-04-22 | Ivan Bergstein | Methods of cancer therapy targeted against a cancer stem line |
| US6004528A (en) | 1997-09-18 | 1999-12-21 | Bergstein; Ivan | Methods of cancer diagnosis and therapy targeted against the cancer stemline |
| US8119101B2 (en) | 1999-05-10 | 2012-02-21 | The Ohio State University | Anti-CD74 immunoconjugates and methods of use |
| US6642009B2 (en) | 1999-05-17 | 2003-11-04 | Cytyc Health Corporation | Isolated ductal fluid sample |
| JP2001057828A (ja) | 1999-08-20 | 2001-03-06 | Toray Ind Inc | 癌性疼痛モデル動物及びそれを用いた癌性疼痛の強さの評価方法 |
| US20020165188A1 (en) | 1999-10-14 | 2002-11-07 | Meenhard Herlyn | Methods for inhibition of tumorigenic properties of melanoma cells |
| US20030129677A1 (en) | 2000-05-12 | 2003-07-10 | Martens Mark G. | Diagnostic method for screening complement regulatory protein levels |
| WO2001088537A1 (en) | 2000-05-12 | 2001-11-22 | Martens Mark G | Diagnostic method for screening complement regulatory protein levels |
| US8044259B2 (en) | 2000-08-03 | 2011-10-25 | The Regents Of The University Of Michigan | Determining the capability of a test compound to affect solid tumor stem cells |
| US6984522B2 (en) | 2000-08-03 | 2006-01-10 | Regents Of The University Of Michigan | Isolation and use of solid tumor stem cells |
| EP1320583B1 (en) | 2000-08-04 | 2006-03-01 | Chiron Corporation | Enhanced replication of hcv rna |
| US20020115065A1 (en) | 2000-08-28 | 2002-08-22 | Ton Logtenberg | Differentially expressed epitopes and uses thereof |
| EP1184458A1 (en) | 2000-08-28 | 2002-03-06 | U-BISys B.V. | Differentially expressed CD46 epitopes, proteinaceous molecules capable of binding thereto, and uses thereof |
| US20030119080A1 (en) | 2001-10-15 | 2003-06-26 | Mangano Joseph A. | Strategies for the identification and isolation of cancer stem cells and non-cancerous stem cells |
| JP4347694B2 (ja) * | 2001-10-16 | 2009-10-21 | レイベン バイオテクノロジーズ，インコーポレイティド | 癌関連抗原ｃｄ４６に結合する抗体およびその使用方法 |
| ATE395413T1 (de) | 2001-12-03 | 2008-05-15 | Amgen Fremont Inc | Antikörperkategorisierung auf der grundlage von bindungseigenschaften |
| US7591994B2 (en) | 2002-12-13 | 2009-09-22 | Immunomedics, Inc. | Camptothecin-binding moiety conjugates |
| CN100516876C (zh) | 2002-11-21 | 2009-07-22 | 惠氏公司 | 用于诊断肾细胞癌(rcc)和其他实体瘤的方法 |
| US7534427B2 (en) * | 2002-12-31 | 2009-05-19 | Immunomedics, Inc. | Immunotherapy of B cell malignancies and autoimmune diseases using unconjugated antibodies and conjugated antibodies and antibody combinations and fusion proteins |
| EP1627912A4 (en) | 2003-05-20 | 2007-12-12 | Riken | PREPARATION OF ENDODERMAL STEM CELLS |
| EP1639090A4 (en) | 2003-06-09 | 2008-04-16 | Univ Michigan | COMPOSITIONS AND METHODS FOR TREATING AND DIAGNOSING CANCER |
| GB0406215D0 (en) | 2004-03-19 | 2004-04-21 | Procure Therapeutics Ltd | Prostate stem cell |
| CA2561073C (en) | 2004-03-27 | 2014-01-14 | The Arizona Board Of Regents On Behalf Of The University Of Arizona | Composition and method for cancer treatment |
| CA2629330C (en) | 2004-11-12 | 2018-05-22 | Cambridge University Technical Services Ltd. | Methods and means related to cancer stem cells |
| CN1940062B (zh) | 2005-09-28 | 2010-04-28 | 上海市肿瘤研究所 | 一种肝癌干细胞及其分离方法和用途 |
| AU2006308847C1 (en) | 2005-10-31 | 2012-05-10 | Oncomed Pharmaceuticals, Inc. | Compositions and methods for treating and diagnosing cancer |
| US20070123448A1 (en) | 2005-11-23 | 2007-05-31 | The Hospital For Sick Children | Novel chemical entities affecting neuroblastoma tumor-initiating cells |
| US20070248628A1 (en) | 2005-12-06 | 2007-10-25 | Keller Lorraine H | Immunogens in cancer stem cells |
| WO2007140410A2 (en) | 2006-05-30 | 2007-12-06 | Van Andel Research Institute | Low-density lipoprotein receptor 6 (lrp6) as a mammary stem cell marker and related methods |
| CA2658003A1 (en) | 2006-06-06 | 2007-12-21 | University Of Tennessee Research Foundation | Compositions enriched in neoplastic stem cells and methods comprising same |
| EP2975057A1 (en) | 2006-07-10 | 2016-01-20 | Fujita Health University | Novel anti-cd73 antibody |
| US20100003189A1 (en) * | 2006-07-14 | 2010-01-07 | The Regents Of The University Of California | Cancer biomarkers and methods of use thereof |
| US20110244501A1 (en) | 2006-08-02 | 2011-10-06 | Biogen Idec Ma Inc. | Cancer stem cells |
| EP2783700A1 (en) | 2006-09-07 | 2014-10-01 | Stemline Therapeutics, Inc. | Cancer stem cell-targeted cancer therapy |
| EP2526970A1 (en) | 2006-09-07 | 2012-11-28 | Stemline Therapeutics, Inc. | Monitoring cancer stem cells |
| EP2076587A4 (en) | 2006-09-11 | 2009-12-09 | Univ Florida | ISOLATION, EXPANSION AND USE OF TUMOR STEM CELLS |
| US7781179B2 (en) | 2006-12-07 | 2010-08-24 | The Board Of Trustees Of The Leland Stanford Junior University | Identification and isolation of transitional cell carcinoma stem cells |
| AU2008207945A1 (en) | 2007-01-22 | 2008-07-31 | Macrogenics West, Inc. | Human cancer stem cells |
| US8148147B2 (en) | 2007-01-24 | 2012-04-03 | The Regents Of The University Of Michigan | Compositions and methods for treating and diagnosing pancreatic cancer |
| WO2008149803A1 (ja) * | 2007-06-06 | 2008-12-11 | The University Of Tokyo | 表面抗原マーカーを用いた急性リンパ性白血病における癌幹細胞の分離同定方法 |
| US9289492B2 (en) | 2007-07-17 | 2016-03-22 | The General Hospital Corporation | Collecting ovarian cancer stem cells from ovarian cancer cells |
| CA2693098C (fr) | 2007-07-19 | 2019-06-18 | Yasemin Ataman-Onal | Procede de dosage de la proteine de liaison hepatique aux acides gras, de l'antigene carcino-embryonnaire, et de l'antigene carbohydrate 19-9 pour le diagnostic in vitro du cancercolorectal |
| US8168586B1 (en) | 2007-11-21 | 2012-05-01 | Celera Corporation | Cancer targets and uses thereof |
| WO2009070767A2 (en) * | 2007-11-28 | 2009-06-04 | Whitehead Institute For Biomedical Research | Systemic instigation systems to study tumor growth or metastasis |
| WO2009126310A2 (en) | 2008-04-10 | 2009-10-15 | Massachusetts Institute Of Technology | Methods for identification and use of agents targeting cancer stem cells |
| BRPI0911427A2 (pt) * | 2008-04-10 | 2015-11-17 | Ibc Pharmaceuticals | complexo por dnl (dock and lock) de anticorpo-citocina, uso de uma composição farmaceutica. |
| EP2295537A4 (en) | 2008-05-14 | 2011-11-30 | Public Univ Corp Yokohama City | HUMAN HEPATIC STRAIN CELL, PREPARATION METHOD THEREFOR, METHOD OF INDUCING ITS DIFFERENTIATION AND METHOD OF USE |
| WO2009157623A1 (en) * | 2008-06-25 | 2009-12-30 | Korea Research Institute Of Bioscience And Biotechnology | Cd9-specific human antibodies |
| WO2010011893A1 (en) | 2008-07-24 | 2010-01-28 | University Of Central Florida Research Foundation, Inc. | Therapy targeting cancer stem cells |
| US20100162416A1 (en) | 2008-09-29 | 2010-06-24 | Stemlifeline, Inc. | Multi-stage stem cell carcinogenesis |
| CN102333891A (zh) | 2009-01-20 | 2012-01-25 | 利兰·斯坦福青年大学托管委员会 | 用于药靶诊断、预后和鉴别的单细胞基因表达 |
| US20110020221A1 (en) | 2009-04-09 | 2011-01-27 | The Johns Hopkins University | Cancer stem cell expression patterns and compounds to target cancer stem cells |
| US20120219506A1 (en) | 2009-11-05 | 2012-08-30 | Sloan Kettering Institute For Cancer Research | Catenae: Serosal Cancer Stem Cells |
| JP5808054B2 (ja) | 2009-12-25 | 2015-11-10 | 中外製薬株式会社 | Ｎｏｇ樹立癌細胞株が移植された非ヒト動物モデルを用いた抗癌剤ターゲット探索及びスクリーニング法 |
| EP2347769A1 (en) | 2010-01-20 | 2011-07-27 | Glycotope GmbH | Cancer stem cell markers and uses thereof |
| CN103260646B (zh) * | 2010-08-27 | 2016-01-13 | 施特姆森特克斯股份有限公司 | Notum蛋白调节剂和使用方法 |
| US20130061342A1 (en) | 2011-09-02 | 2013-03-07 | Stem Centrx, Inc. | Identification and Enrichment of Cell Subpopulations |
| AU2011295722B2 (en) | 2010-09-03 | 2016-04-21 | Abbvie Stemcentrx Llc | Identification and enrichment of cell subpopulations |
| US9778264B2 (en) | 2010-09-03 | 2017-10-03 | Abbvie Stemcentrx Llc | Identification and enrichment of cell subpopulations |
| WO2013119964A2 (en) | 2012-02-08 | 2013-08-15 | Stem Centrx, Inc. | Identification and enrichment of cell subpopulations |
| US20130061340A1 (en) | 2011-09-02 | 2013-03-07 | Stem Centrx, Inc. | Identification and Enrichment of Cell Subpopulations |
| SG188666A1 (en) | 2010-09-30 | 2013-05-31 | Agency Science Tech & Res | Methods and reagents for detection and treatment of esophageal metaplasia |
| EP2621955B1 (en) | 2010-10-01 | 2018-01-17 | National Research Council of Canada | Anti-ceacam6 antibodies and uses thereof |
| GB201016852D0 (en) | 2010-10-07 | 2010-11-17 | Univ York | Cell differentiation |
| SA112330278B1 (ar) | 2011-02-18 | 2015-10-09 | ستيم سينتركس، انك. | مواد ضابطة جديدة وطرق للاستخدام |
| ES2871418T3 (es) | 2013-08-28 | 2021-10-28 | Abbvie Stemcentrx Llc | Composiciones y métodos de conjugación de anticuerpos específicos de sitio |
| US20190209704A1 (en) | 2014-10-20 | 2019-07-11 | Igenica Biotherapeutics, Inc. | Novel antibody-drug conjugates and related compounds, compositions and methods of use |
-
2011
- 2011-09-02 AU AU2011295722A patent/AU2011295722B2/en not_active Ceased
- 2011-09-02 WO PCT/US2011/050451 patent/WO2012031280A2/en active Application Filing
- 2011-09-02 SG SG10201506767QA patent/SG10201506767QA/en unknown
- 2011-09-02 US US13/820,061 patent/US9945842B2/en not_active Expired - Fee Related
- 2011-09-02 SG SG2013024310A patent/SG189212A1/en unknown
- 2011-09-02 EP EP11788622.6A patent/EP2611463A2/en not_active Withdrawn
- 2011-09-02 EP EP13190308.0A patent/EP2689787A1/en not_active Withdrawn
- 2011-09-02 JP JP2013527364A patent/JP6240504B2/ja not_active Expired - Fee Related
- 2011-09-02 CN CN201180053062.3A patent/CN103313726B/zh not_active Expired - Fee Related
- 2011-09-02 CN CN201610542229.7A patent/CN106434561A/zh active Pending
- 2011-09-02 CA CA2809864A patent/CA2809864A1/en not_active Abandoned
-
2016
- 2016-03-02 JP JP2016040197A patent/JP2016104037A/ja active Pending
- 2016-03-18 AU AU2016201730A patent/AU2016201730B2/en not_active Ceased
-
2017
- 2017-08-21 JP JP2017158414A patent/JP2018023387A/ja not_active Withdrawn
- 2017-12-29 AU AU2017279835A patent/AU2017279835A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EP2689787A1 (en) | 2014-01-29 |
| AU2017279835A1 (en) | 2018-01-25 |
| JP2016104037A (ja) | 2016-06-09 |
| CA2809864A1 (en) | 2012-03-08 |
| JP2013539966A (ja) | 2013-10-31 |
| US20130260385A1 (en) | 2013-10-03 |
| AU2011295722A1 (en) | 2013-05-02 |
| AU2011295722B2 (en) | 2016-04-21 |
| CN103313726B (zh) | 2016-08-17 |
| JP6240504B2 (ja) | 2017-11-29 |
| US9945842B2 (en) | 2018-04-17 |
| JP2018023387A (ja) | 2018-02-15 |
| AU2016201730A1 (en) | 2016-04-07 |
| AU2016201730B2 (en) | 2018-01-25 |
| CN106434561A (zh) | 2017-02-22 |
| WO2012031280A3 (en) | 2012-07-12 |
| SG189212A1 (en) | 2013-05-31 |
| WO2012031280A2 (en) | 2012-03-08 |
| CN103313726A (zh) | 2013-09-18 |
| EP2611463A2 (en) | 2013-07-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG10201506767QA (en) | Identification and enrichment of cell subpopulations | |
| HK1251033A1 (zh) | 全細胞分析和方法 | |
| EP2613400A4 (en) | BATTERY AND BATTERY SYSTEM | |
| EP2592933A4 (en) | MIF INHIBITORS AND USES THEREOF | |
| EP2591797A4 (en) | FACTOR FOR REGULATING FOXP3 AND REGULATORY T CELLS AND USE THEREOF | |
| IL222961A0 (en) | Novel dna-dinding proteins and uses thereof | |
| EP2600878A4 (en) | REGULATORY B-CELLS AND ITS USES | |
| SG10201912164UA (en) | System for identifying and sorting living cells | |
| EP2640854A4 (en) | CNNA AND USES THEREOF | |
| EP2596006A4 (en) | METHODS AND SYSTEMS FOR ANALYZING ISOLATED CELLS | |
| PT2946791T (pt) | Anticorpos anti-cd277 e suas utilizações | |
| HK1179981A1 (zh) | 的抗體及其用途 | |
| EP2543999A4 (en) | CELL DETECTION METHOD AND CELL DETECTION SYSTEM | |
| EP2833431C0 (en) | TEST BATTERY BOX AND TEST BATTERY | |
| HK1214412A1 (zh) | 電化學生物反應器模塊和使用所述模塊的方法 | |
| EP2632952A4 (en) | ANTI-SOD1 ANTIBODIES AND USES THEREOF | |
| EP2635674A4 (en) | MARKERS FOR ENDOTHELIAL STORAGE CELLS AND USES THEREOF | |
| IL252113B (en) | Subpopulations of spore-like cells and their uses | |
| EP2608785A4 (en) | LIPOMA CYCLES AND ITS USES | |
| GB201121170D0 (en) | Galvanic cells and components therefore | |
| EP2553115A4 (en) | METHODS OF CULTURE AND ANALYSIS OF CELLS | |
| EP2525900A4 (en) | NITROGEN PERMANENT MEMBRANES AND USES THEREOF | |
| EP2624065A4 (en) | LOAD ELEMENT AND MANUFACTURING METHOD THEREFOR | |
| GB201017820D0 (en) | Cells and devices | |
| EP2529013A4 (en) | NOVEL BETA GLUCOSIDASE AND USES THEREOF |